These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13743435)

  • 1. Coagulant and fibrinolytic activity of animal venoms; determination of coagulant and fibrinolytic index of different species.
    ROSENFELD G; HAMPE OG; KELEN EM
    Mem Inst Butantan; 1959; 29():143-63. PubMed ID: 13743435
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic and coagulant activities of certain snake venoms and proteases.
    DIDISHEIM P; LEWIS JH
    Proc Soc Exp Biol Med; 1956 Oct; 93(1):10-3. PubMed ID: 13370561
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulant and anticoagulant agents in snke venoms.
    de KLOBUSITZKY
    Am J Med Sci; 1961 Jul; 242():107-23. PubMed ID: 13756917
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of coagulant principles in snake venoms by dextran sulfate, a synthetic anticoagulant of bacterial origin].
    GRASSET E; SCHWARTZ DE
    Schweiz Z Pathol Bakteriol; 1954; 17(4):514-20. PubMed ID: 13225707
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the fibrinolytic and circulatory effect of nicotinic acid with special reference to its therapeutic usefulness].
    EGLI H; KLENSCH H
    Med Welt; 1961 Oct; 41():2108-13. PubMed ID: 13889445
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulant and anticoagulant actions of Australian snake venoms.
    Marshall LR; Herrmann RP
    Thromb Haemost; 1983 Oct; 50(3):707-11. PubMed ID: 6648891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of the clotting and fibrinolytic activities of the snake venom (Bothrops atrox) from different geographical areas in Venezuela.
    Salazar AM; Rodriguez-Acosta A; Girón ME; Aguilar I; Guerrero B
    Thromb Res; 2007; 120(1):95-104. PubMed ID: 17045631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effects of heparin and dextran sulfate alone and combined with ACTH and cortisone, on the coagulant action of viper venoms].
    GRASSET E; SCHWARTZ DE
    Bull Schweiz Akad Med Wiss; 1955 May; 11(1-2):10-22. PubMed ID: 14389908
    [No Abstract]   [Full Text] [Related]  

  • 9. Individual variability in the venom proteome of juvenile Bothrops jararaca specimens.
    Dias GS; Kitano ES; Pagotto AH; Sant'anna SS; Rocha MM; Zelanis A; Serrano SM
    J Proteome Res; 2013 Oct; 12(10):4585-98. PubMed ID: 23998483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulant thrombin-like enzyme (barnettobin) from Bothrops barnetti venom: molecular sequence analysis of its cDNA and biochemical properties.
    Vivas-Ruiz DE; Sandoval GA; Mendoza J; Inga RR; Gontijo S; Richardson M; Eble JA; Yarleque A; Sanchez EF
    Biochimie; 2013 Jul; 95(7):1476-86. PubMed ID: 23578498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry and pharmacology of polypeptide toxins in snake venoms.
    Lee CY
    Annu Rev Pharmacol; 1972; 12():265-86. PubMed ID: 4339019
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in RVBCMP.
    Mukherjee AK
    Toxicon; 2008 Apr; 51(5):923-33. PubMed ID: 18249434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical properties and comparative pharmacology of a coagulant from Deinagkistrodon acutus snake venom.
    Tang SS; Wang XH; Zhang JH; Tang BS; Qian L; Li PY; Luo LW
    Eur J Pharm Sci; 2013 Apr; 49(1):90-8. PubMed ID: 23429184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraspecific differences in the immunochemical reactivity and neutralization of venom from Argentinean Bothrops (Rhinocerophis) alternatus by specific experimental antivenoms.
    Lanari LC; Alagón A; Costa de Oliveira V; Laskowicz RD; Boyer L; Lago NR; Alejandro A; de Roodt AR
    Toxicon; 2014 Jul; 85():31-45. PubMed ID: 24769139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs.
    Wygrecka M; Markart P; Ruppert C; Petri K; Preissner KT; Seeger W; Guenther A
    Eur Respir J; 2007 Jun; 29(6):1105-14. PubMed ID: 17331968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxinology of venoms from five Australian lesser known elapid snakes.
    Pycroft K; Fry BG; Isbister GK; Kuruppu S; Lawrence J; Ian Smith A; Hodgson WC
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):268-74. PubMed ID: 22682331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood flow and blood pressure after noradrenaline infusions.
    LEVER AF; MOWBRAY JF; PEART WS
    Clin Sci; 1961 Aug; 21():69-74. PubMed ID: 13761362
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in the pharmacology of the regulation of blood circulation, maintenance of temperature and respiration].
    HAHN F
    Regensb Jahrb Arztl Fortbild; 1961 May; 9():8-16. PubMed ID: 13710562
    [No Abstract]   [Full Text] [Related]  

  • 19. Species differences in effect of gram-negative endotoxin on circulation.
    KUIDA H; GILBERT RP; HINSHAW LB; BRUNSON JG; VISSCHER MB
    Am J Physiol; 1961 Jun; 200():1197-202. PubMed ID: 13754972
    [No Abstract]   [Full Text] [Related]  

  • 20. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.